Isolation and characterization of a potentially novel Siphoviridae phage (vB_SsapS-104) with lytic activity against Staphylococcus saprophyticus isolated from urinary tract infection
Antibiotic resistance is increasing among Staphylococcus saprophyticus strains isolated from urinary tract infection. This necessitates alternative therapies. For this, a lytic phage (vB_SsapS-104) against S. saprophyticus, which formed round and clear plaques on bacterial culture plates, was isolated from hospital wastewater and characterized. Microscopy analysis showed that it had a small head (about 50 nm), tail (about 80 nm), and a collar (about 22 nm in length and 19 nm in width) indicating to be a phage within Siphoviridae family. Phage vB_SsapS-104 showed a large latency period of about 40 min, rapid adsorption rate that was significantly enhanced by MgCl2 and CaCl2, and high stability to a wide range of temperatures and pH values. Restriction analyses demonstrated that phage consists of a double-stranded DNA with an approximate genome size of 40 Kb. BLAST results did not show high similarity (megablast) with other previously identified phages. But, in Blastn, similarity with Staphylococcus phages was observed. Phage vB_SsapS-104 represented high anti-bacterial activity against S. saprophyticus isolates in vitro as it was able to lyse 8 of the 9 clinical isolates (%88.8) obtained from a hospital in Gorgan, Iran. It was a S. saprophyticus-specific phage because no lytic activity was observed on some other pathogenic bacteria tested. Therefore, phage vB_SsapS-104 can be considered as a specific virulent phage against of S. saprophyitcus isolated from urinary tract infection. This study provided the partial genomic characterization of S. saprophyticus phage and its application against urinary tract infection associated with S. saprophyticus. This phage also can be considered as a good candidate for a therapeutic alternative in the future.
KeywordsStaphylococcus saprophyticus Urinary tract infection Siphoviridae Lytic bacteriophage
This study was financially supported by a joint grant from the University of Isfahan and Golestan University of Medical Sciences, Iran [35/219525].
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Bes M, Ackermann HW, Brun Y, Fleurette J (1990) Morphology of Staphylococcus saprophyticus bacteriophagesGoogle Scholar
- Estrella LA, Quinones J, Henry M, Hannah RM, Pope RK, Hamilton T, Teneza-mora N, Biswajit EH (2016) Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the OmniLog® system. Bacteriophage 6(3):e1219440. https://doi.org/10.1080/21597081.2016.1219440 CrossRefPubMedPubMedCentralGoogle Scholar
- Komijani M, Bouzari M, Rahimi F (2016) Detection and characterization of a novel lytic bacteriophage (vB-KpneM-Isf48) against Klebsiella pneumoniae isolates from infected wounds carrying antibiotic-resistance genes (TEM, SHV, and CTX-M). Iran Red Crescent Med J 19:e34475. https://doi.org/10.5812/ircmj.34475 CrossRefGoogle Scholar
- Łobocka M et al (2012) Genomics of staphylococcal Twort-like phages—potential therapeutics of the post-antibiotic era. Adv Virus Res 83:143–216. https://doi.org/10.1016/B978-0-12-394438-2.00005-0 CrossRefPubMedGoogle Scholar
- Nivas D, Ramesh N, Krishnakumar V, Rajesh P, Solomon EK, Kannan VR (2015) Distribution, isolation and characterization of lytic bacteriophages against multi-drug resistant and extended-spectrum of β-lactamase producing pathogens from hospital effluents. Asian J Pharm Clin Res 8:384–389Google Scholar
- O’flaherty S, Ross R, Flynn J, Meaney W, Fitzgerald G, Coffey A (2005a) Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections. Lett Appl Microbiol 41:482–486. https://doi.org/10.1128/AEM.71.4.1836-1842.2005 CrossRefPubMedGoogle Scholar
- O’flaherty S, Ross R, Meaney W, Fitzgerald G, Elbreki M, Coffey A (2005b) Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71:1836–1842. https://doi.org/10.1128/AEM.71.4.1836-1842.2005 CrossRefPubMedPubMedCentralGoogle Scholar
- O’flaherty S, Flynn J, Coffey A, Fitzgerald G, Meaney WJ, Ross RP (2006) Molecular characterisation of bacteriophage K towards applications for the biocontrol of pathogenic staphylococci. Doctoral thesis University College, Cork, IrelandGoogle Scholar
- Patel J, Cockerill F, Alder J, Bradford P, Eliopoulos G, Hardy D (2014) Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI standards for antimicrobial susceptibility testing 34:1–226Google Scholar
- Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning vol 2. Cold Spring Harbor Laboratory Press, New YorkGoogle Scholar
- Synnott AJ, Kuang Y, Kurimoto M, Yamamichi K, Iwano H, Tanji Y (2009) Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl Environ Microbiol 75:4483–4490. https://doi.org/10.1128/AEM.02641-08 CrossRefPubMedPubMedCentralGoogle Scholar
- Widerström M, Wiström J, Ferry S, Karlsson C, Monsen T (2007) Molecular epidemiology of Staphylococcus saprophyticus isolated from women with uncomplicated community-acquired urinary tract infection. J Clin Microbiol 45:1561–1564. https://doi.org/10.1128/JCM.02071-06 CrossRefPubMedPubMedCentralGoogle Scholar
- Zamani I, Bouzari M, Emtiazi G, Ghasemi SM, Chang HI (2014) Complete genome sequence of a novel phage, vB_MoxS-ISF9, infecting methylotrophic microbacterium: first report of a virulent microbacterium phage. Arch Virol 159:2537–2540. https://doi.org/10.1007/s00705-014-2092-5 CrossRefPubMedGoogle Scholar